Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Insulin Pump Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type, By Disease Indication, By Distribution Channel, and Region
In the insulin pump market, the insulin pumps sold in 2023 were around 1,700 million units and are expected to register a CAGR of 3.5% during the forecast period, with a volume of 2,171 million units expected to be sold. An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The major driving factors for this market include the rising prevalence of diabetes, technological advancements, and improved patient outcomes.
According to its estimates, IDF reports a very high and increasing global prevalence of diabetes, in 2021, around 10.5% of the adult population of the age group 20-79 years was reported to be suffering from diabetes. That would amount to approximately 537 million adults in the world, and by 2045 there would be 783 million adults affected with diabetes, which is almost every 1 in 8 adults. This is driven by factors such as urbanization, aging of the population, decreased levels of physical activity, and rising overweight and obesity rates. This changing prevalence ratio coincides with a growing demand for effective management tools such as pumps. Individuals with Type 1 diabetes are in special need of substitute insulin administration to keep glucose levels at normal values. Because pumps are more convenient and a more effective way of taking insulin, they have become very popular with this patient population.
However, constraints such as competition from other insulin delivery devices, high cost, and limited insurance coverage and these constraints are overcome by product innovation, expanding market segments, and expansion in emerging markets. Some current trends in the insulin pump market are increasing demand for integration with digital health and a focus on patient experience.
Study Period
2024-2030Base Year
2023CAGR
3.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The major restraint in the insulin pump market is the high cost, these novel drug delivery devices have disrupted traditional healthcare dynamics and revolutionized the healthcare industry. However, higher associated costs with these devices and supplies make access inadequate for people in low and middle-income countries. Moreover, a general lack of awareness about the treatment alternatives for diabetes and poor reimbursement policies in developing nations are the reasons for the low adoption of these pumps in emerging economies. Furthermore, higher out-of-pocket spending associated with these pumps has also reduced its adoption amongst patients.
For instance, according to an article released by the American Diabetes Association in April 2019, in patients with diabetes, insulin pump therapy is usually more expensive than MDI therapy, at 12,928 USD compared with 9,005 USD with a nearly 43.5 percent cost difference.
Increasing diabetic patients lead to the high requirement for insulin devices and hence leading to the insulin pumps and accessories industry growth. There are several factors that contribute greatly in booming the market of insulin pumps growth such as increasing demand for ambulatory infusion pumps, fast growth in the aged population, increasing cases of surgical procedures and increasing incidence of chronic illnesses like diabetes and gastrointestinal disorders.
On the other hand, precise government rules to approve devices and errors coming when using the infusion pump accessories lead to several product recalls, which limit the growth of market. The Increase in insulin price with unfavorable insurance policies is anticipated to hinder the market growth during the forecast period. The increasing preference towards naturopathy is a crucial factor to limit the market growth in upcoming years. Another major hurdle which can control market growth is the obligation of severe regulations for the approval of the product.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
3.5% |
By Product Type |
|
By Disease |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
The global insulin Pump market size was valued at US$ 1,700 million in 2023 and is poised to grow at a CAGR of 3.5% from 2024-2030.
• Rising Prevalence of Diabetes
• Technological Advancements
• Improved Patient Outcomes
• Integration with Digital Health
• Focus on Patient Experience.
North America is the dominating region in the insulin pump market.
Asia-Pacific is the fastest region in the insulin pump market.
1.Executive Summary |
2.Global Insulin Pump Market Introduction |
2.1.Global Insulin Pump Market - Taxonomy |
2.2.Global Insulin Pump Market - Definitions |
2.2.1.Product Type |
2.2.2.Disease |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Insulin Pump Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Insulin Pump Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Insulin Pump Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Pumps |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Consumables |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Insulin Pump Market By Disease, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Type 1 Diabetes |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Type 2 Diabetes |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Insulin Pump Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital Pharmacy |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail & Online Pharmacy |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.10. Valeritas, Inc |
7.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.10.3. Market Opportunity Analysis |
8.Global Insulin Pump Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Insulin Pump Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Pumps |
9.1.2.Consumables |
9.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Type 1 Diabetes |
9.2.2.Type 2 Diabetes |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacy |
9.3.2.Retail & Online Pharmacy |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Insulin Pump Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pumps |
10.1.2.Consumables |
10.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Type 1 Diabetes |
10.2.2.Type 2 Diabetes |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacy |
10.3.2.Retail & Online Pharmacy |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Insulin Pump Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pumps |
11.1.2.Consumables |
11.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Type 1 Diabetes |
11.2.2.Type 2 Diabetes |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacy |
11.3.2.Retail & Online Pharmacy |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Insulin Pump Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Pumps |
12.1.2.Consumables |
12.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Type 1 Diabetes |
12.2.2.Type 2 Diabetes |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacy |
12.3.2.Retail & Online Pharmacy |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Insulin Pump Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Pumps |
13.1.2.Consumables |
13.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Type 1 Diabetes |
13.2.2.Type 2 Diabetes |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacy |
13.3.2.Retail & Online Pharmacy |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Medtronic |
14.2.2.Hoffmann-La Roche AG |
14.2.3.Tandem Diabetes Care, Inc. |
14.2.4.Insulet Corporation |
14.2.5.Ypsomed |
14.2.6.Sanofi S.A. |
14.2.7.Sooil development |
14.2.8.Jiangsu Delfu Co., Ltd. |
14.2.9.Cellnovo Ltd |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players